There's Now a $1-a-Pill Competitor to Pharma CEO Martin Shkreli's $750-a-Pill DrugBusiness InsiderOct. 23, 2015 |
Biden Commutes Sentences of 37 of 40 Federal Death Row Inmates - Excludes Robert Bowers, Dylann Roof
'This is Cruelty, This is Not War': Pope Francis Condemns Gaza Genocide in Christmas Message
U.S. 'Shoots Down Own Jet' Over Red Sea in 'Friendly Fire Incident'
Ohio Senate Passes Bill Aimed at Outlawing Criticism of Israel, Criminalizing Gospel
Putin Accuses 'Ethnic Jews' of Tearing Russian Orthodox Church Apart
Almost a month after word got out that drug-company CEO Martin Shkreli had jacked up the price of a critical drug by more than 5,000%, a different kind of pharma company has stepped up to provide a cheaper alternative. Read More |